{"id":13401,"date":"2024-08-23T00:11:26","date_gmt":"2024-08-22T22:11:26","guid":{"rendered":"https:\/\/valintermed.com\/?p=13401"},"modified":"2024-08-23T00:11:26","modified_gmt":"2024-08-22T22:11:26","slug":"sindrom-unferrihta-lundborga","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/","title":{"rendered":"Unferricht-Lundborg syndrome"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Unverricht-Lundborg syndrome (ULS) is a rare genetic disorder characterized by edema syndrome, carbohydrate metabolism disorder, and hemolytic anemia. The disease is caused by disturbances in the functioning of certain enzymes, which leads to accumulation of metabolites and manifestation of clinical symptoms. The main manifestations of the syndrome are progressive neurological disorders, growth disorders, and hematological abnormalities. An important aspect of this disease is its association with metabolic disorders, which can undermine the patient&#039;s health at various levels. ULS is a systemic disease that requires a comprehensive approach to diagnosis and treatment.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/lundborg-unfermented-syndrome\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Unverricht-Lundborg syndrome was first described in the mid-20th century. The disease became an object of interest after several clinical observations revealed its similarity to another genetic disorder. Research conducted in the 1970s and 1980s established a link between the syndrome and certain mutations in genes responsible for carbohydrate and lipid metabolism. A full understanding of the pathogenesis of the syndrome was achieved with the development of molecular genetics, which in turn opened up new horizons for diagnosis and therapy. Interestingly, in their works, scientists emphasized that the syndrome can manifest itself differently depending on ethnicity and age group, emphasizing the importance of an individual approach to the patient.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Data on the prevalence of Unverricht-Lundborg syndrome are limited because the disorder is rare. Estimates indicate that there are approximately 1-2 cases of ULS per million population. The majority of affected individuals are young children, although the disorder can also occur in adults. Prevalence varies among populations, possibly due to both genetic and environmental factors. Because the disorder is genetic, a higher incidence would be expected among individuals with a family history of similar disorders. Identifying and documenting all cases remains an ongoing task to better understand its prevalence and trends.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Unverricht-Lundborg syndrome has a strong genetic predisposition. To date, it has been established that mutations occur in several key genes responsible for the synthesis of enzymes involved in carbohydrate metabolism. In particular, important changes have been identified in the genes encoding a-amylase and glucosyltransferase. These genetic changes interfere with the normal functioning of metabolic pathways, which in turn leads to the accumulation of toxic metabolites and the development of disease symptoms. Certain mutations are associated with more severe forms of the syndrome, while others may manifest with milder symptoms. Genetic testing is key to diagnosing the syndrome, especially in cases with a family history of the disease.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Unverricht-Lundborg syndrome is primarily associated with genetic factors, but certain environmental and physical conditions may serve as additional triggers for its manifestation. <\/p>\n<ul>\n<li>Hereditary predisposition - having a case in the family significantly increases the risk of developing the syndrome.<\/li>\n<li>Environmental factors - exposure to certain toxic substances may worsen the symptoms of an existing syndrome.<\/li>\n<li>Physical trauma - brain injuries can also influence the manifestation of the syndrome, increasing neurological symptoms.<\/li>\n<li>Vitamin or mineral deficiencies (eg, vitamin B12 deficiency) may contribute to the hemolytic anemia associated with the syndrome.<\/li>\n<li>Other comorbidities, such as endocrine disorders, may also worsen the clinical picture.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of Unverricht-Lundborg syndrome is based on a comprehensive approach, including both clinical and laboratory examination. The main symptoms include:<\/p>\n<ul>\n<li>Neurological disorders: developmental delays, seizures, problems with coordination.<\/li>\n<li>Anemia: severe fatigue, pallor, shortness of breath.<\/li>\n<li>Edema: noticeable in the lower limbs and in the abdominal area.<\/li>\n<\/ul>\n<p>Laboratory tests may include:<\/p>\n<ul>\n<li>A comprehensive blood test to assess Hb levels, the number of formed elements and the presence of reticulocytes.<\/li>\n<li>Biochemical tests to determine the activity of carbohydrate metabolites.<\/li>\n<li>Genetic testing to identify mutations associated with the syndrome.<\/li>\n<\/ul>\n<p>Radiological examinations such as MRI of the brain help to identify possible anatomical abnormalities, while functional tests can evaluate the activity of certain enzymes. It is important to note the need for differential diagnosis with other metabolic disorders such as von Gierke disease. This will help to exclude other possible causes of similar clinical symptoms.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of Unverricht-Lundborg syndrome requires an individual approach and may include both pharmacological and non-pharmacological therapy. General recommendations include:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li>Supportive therapy: dietary modification aimed at improving metabolism.<\/li>\n<li>Pharmacological treatment: use of drugs to correct anemia and other associated symptoms.<\/li>\n<li>Surgery: In rare cases, surgery may be required to remove mechanical obstructions.<\/li>\n<li>Other types of treatment: physiotherapy, rehabilitation to improve functional status and quality of life.<\/li>\n<\/ul>\n<p>It is important that all treatment decisions are made by a multidisciplinary team, including doctors from different specialties, to achieve the best results.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Medications used to treat Unverricht-Lundborg syndrome may include:<\/p>\n<ul>\n<li>Ferritin - to correct iron deficiency anemia.<\/li>\n<li>Vitamin B12 - to eliminate deficiency and improve metabolism.<\/li>\n<li>Erythropoietin - to stimulate the production of red blood cells.<\/li>\n<li>Drugs to support carbohydrate metabolism, such as insulin or sugar suppressors.<\/li>\n<\/ul>\n<p>It is important to note that the selection of drugs should be carried out by a doctor, taking into account the individual characteristics of the patient.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of the patient&#039;s condition with Unverricht-Lundborg syndrome is carried out on a regular basis. The main control stages include:<\/p>\n<ul>\n<li>Regular visits to the doctor to assess the general condition and adjust treatment.<\/li>\n<li>Laboratory tests to monitor hemoglobin levels and other indicators.<\/li>\n<li>Assessment of neurological functions: periodic examinations to monitor developmental dynamics.<\/li>\n<\/ul>\n<p>The prognosis with adequate treatment can be relatively favorable, but complications such as chronic heart and kidney disease are possible, requiring constant monitoring and additional therapy.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Unverricht-Lundborg syndrome can manifest itself with varying degrees of severity depending on the age of the patient. In children, symptoms may be more pronounced, including developmental delays and severe neurological disorders. In adults, the syndrome may manifest itself less clearly, but with age, the risk of complications increases, especially in relation to the cardiovascular system and kidneys. Therefore, it is important to take age-related features into account when diagnosing and choosing treatment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What is Unverricht-Lundborg syndrome?<\/strong> Unverricht-Lundborg syndrome is a rare genetic disorder characterized by impaired carbohydrate metabolism and hemolytic anemia, manifested by neurological disorders and edema.<\/li>\n<li><strong>Who should be especially wary of this disease?<\/strong> Those most at risk are children with a family history of the disease and people exposed to certain toxic substances.<\/li>\n<li><strong>How is Unverricht-Lundborg syndrome diagnosed?<\/strong> Diagnosis includes clinical examination, laboratory tests and genetic testing, as well as radiological studies if necessary.<\/li>\n<li><strong>What is the treatment for this syndrome?<\/strong> Treatment includes supportive care, pharmacological treatment, and in rare cases, surgery.<\/li>\n<li><strong>What is the prognosis for Unverricht-Lundborg syndrome?<\/strong> The prognosis with adequate treatment can be favorable, but constant monitoring of the patient&#039;s condition is required due to possible complications.<\/li>\n<\/ul>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Unverricht-Lundborg syndrome (ULS) is a rare genetic disorder characterized by edema syndrome, carbohydrate metabolism disorder, and hemolytic anemia. The disease is caused by abnormalities<\/p>","protected":false},"author":1,"featured_media":24118,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-13401","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13401","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=13401"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13401\/revisions"}],"predecessor-version":[{"id":13516,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/13401\/revisions\/13516"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media\/24118"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=13401"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=13401"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=13401"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}